![Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen – World's First and Only Drug-Eluting Contact Lens Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen – World's First and Only Drug-Eluting Contact Lens](https://www.jjvision.com/sites/default/files/styles/large/public/press-release-images/20220228_acuvuePR1.png?itok=ngqy_Zv5)
Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen – World's First and Only Drug-Eluting Contact Lens
![Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management](https://www.jjvision.com/sites/default/files/styles/large/public/press-release-images/abiliti_logo_0.png?itok=wvzLUdhA)
Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management
![FDA Advisory No. 2019-176 || Public Health Warning Against the Purchase and Use of Unregistered Medical Devices: - Food and Drug Administration FDA Advisory No. 2019-176 || Public Health Warning Against the Purchase and Use of Unregistered Medical Devices: - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/02/FDA-Advisory-No.2019-176.jpg)